Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990–2019
-
Published:2024-01-25
Issue:1
Volume:24
Page:
-
ISSN:1472-6874
-
Container-title:BMC Women's Health
-
language:en
-
Short-container-title:BMC Women's Health
Author:
Azangou-Khyavy MohammadrezaORCID, Ghasemi Erfan, Rezaei NegarORCID, Khanali JavadORCID, Kolahi Ali-AsgharORCID, Malekpour Mohammad-RezaORCID, Heidari‐Foroozan MahsaORCID, Nasserinejad Maryam, Mohammadi EsmaeilORCID, Abbasi-Kangevari MohsenORCID, Ghamari Seyyed-HadiORCID, Ebrahimi Narges, Koolaji Sogol, Khosravifar Mina, Fateh Sahar Mohammadi, Larijani BagherORCID, Farzadfar FarshadORCID
Abstract
Abstract
Background and objective
Cervical cancer is the most preventable and ovarian cancer is the most lethal gynecological cancer. However, in the world, there are disparities in health care performances resulting in differences in the burden of these cancers. The objective of this study was to compare the health-system quality of care and inequities for these cancers using the Quality of Care Index (QCI).
Material and methods
The 1990–2019 data of the Global Burden of Disease (GBD) was analyzed to extract rates of incidence, prevalence, mortality, Disability-Adjusted Life Years (DALYs), Years of Life Lost (YLL), and Years of healthy life lost due to disability (YLD) of cervical and ovarian cancer. Four indices were developed as a proxy for the quality of care using the above-mentioned rates. Thereafter, a Principal Components Analysis (PCA) was applied to construct the Quality of Care Index (QCI) as a summary measure of the developed indices.
Results
The incidence of cervical cancer decreased from 1990 to 2019, whereas the incidence of ovarian cancer increased between these years. However, the mortality rate of both cancers decreased in this interval. The global age-standardized QCI for cervical cancer and ovarian cancer were 43.1 and 48.5 in 1990 and increased to 58.5 and 58.4 in 2019, respectively. QCI for cervical cancer and ovarian cancer generally decreased with aging, and different age groups had inequitable QCIs. Higher-income countries generally had higher QCIs for both cancers, but exceptions were also observed.
Conclusions
Uncovering disparities in cervical and ovarian cancer care across locations, Socio-Demographic Index levels, and age groups necessitate urgent improvements in healthcare systems for equitable care. These findings underscore the need for targeted interventions and prompt future research to explore root causes and effective strategies for narrowing these gaps.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference61 articles.
1. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–68. 2. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789–858. 3. Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133:353–61 Academic Press Inc. 4. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, HaieMeder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2018;127(3):404–16. 5. Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Rouhifard Khalilabad M, et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disord. 2020;27:1–7.
|
|